Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
65 hedge funds and large institutions have $270M invested in Syneron Medical Ltd in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
7% more funds holding
Funds holding: 61 → 65 (+4)
3% less capital invested
Capital invested by funds: $278M → $270M (-$8.38M)
37% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
+$8.04M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$2.26M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.64M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
+$1.22M |
| 5 |
SC
Sophrosyne Capital
New York
|
+$725K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$10.2M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$2.33M |
| 3 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$647K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$634K |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$619K |
ELOS Hedge Fund Activity: Q3 2014 in Review
65 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2014, worth a combined $270M — down 3% from $278M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ELOS positions and 7 closed out — a net gain of 5 holders — while 12 added to existing stakes and 19 trimmed.
The largest buyer was Dalton, Greiner, Hartman, Maher & Co, opening a new position worth an estimated $8.04M. The largest seller was Baupost Group, cutting an estimated $10.2M.
- 65 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2014, up from 61 in Q2 2014.
- Funds reported $270M of Syneron Medical Ltd stock for Q3 2014, down 3% quarter-over-quarter.
- 12 funds opened new Syneron Medical Ltd positions in Q3 2014 and 7 closed out, a net change of +5 holders.
- The largest Syneron Medical Ltd buyer in Q3 2014 was Dalton, Greiner, Hartman, Maher & Co, an estimated $8.04M added.
- The largest Syneron Medical Ltd seller in Q3 2014 was Baupost Group, an estimated $10.2M sold.
Based on aggregated 13F filings for Q3 2014.